Key Developments: WebMD Health Corp (WBMD.O)

WBMD.O on Nasdaq

50.04USD
22 Jul 2014
Price Change (% chg)

$0.10 (+0.20%)
Prev Close
$49.94
Open
$50.18
Day's High
$50.96
Day's Low
$49.93
Volume
639,957
Avg. Vol
578,831
52-wk High
$53.30
52-wk Low
$28.03

Search Stocks

Latest Key Developments (Source: Significant Developments)

WebMD Health Corp commences litigation against Everyday Health for Trademark Infringement
Thursday, 19 Jun 2014 04:01pm EDT 

WebMD Health Corp:Says that its subsidiary, WebMD LLC, has commenced litigation against Everyday Health Media LLC, a subsidiary of Everyday Health, Inc., for trademark infringement, false advertising and unfair competition.WebMD's complaint, filed in the United States District Court for Southern District of New York, shows that Everyday Health is using WebMD trademark on Everyday Health's web pages, in Everyday Health website addresses, and in search advertising campaigns.To deceive and mislead consumers into believing they are visiting WebMD's trusted health and wellness resources.WebMD believes that these practices also mislead advertisers whose ads are placed by Everyday Health on areas of its website that infringe WebMD's brands.These activities infringe on WebMD's trademarks and go well beyond the legally permissible practice of simply buying search terms against a competitor's name.  Full Article

WebMD Health Corp gives Q2 2014 outlook in line with analysts' estimates
Wednesday, 30 Apr 2014 04:00pm EDT 

WebMD Health Corp:Sees Q2 2014 revenue to be about $137 to $140 million increase of about 9 to 12 pct from the prior year period.Q2 2014 adjusted EBITDA to be about $35.5 to $37.5 million, an increase of about 21 to 28 pct from the prior year period.Q2 2014 net income is expected to be about $7.5 to $8.5 million.Q2 2014 revenue of $140 mln, EBITDA of $36 mln and net income of $7.9 mln - Thomson Reuters I/B/E/S.  Full Article

WebMD Health Corp raises low end of prior FY, Q1 2014 outlook; raises Q1 2014 earnings outlook
Monday, 14 Apr 2014 07:30am EDT 

WebMD Health Corp:Expects Q1 2014 revenue to be at the high end of the range previously provided.Q1 2014 earnings before interest, taxes, non-cash and other items (adjusted EBITDA) and net income to be slightly above the high end of the range.Expects FY 2014 to be in the top half of the ranges previously provided for revenue, Adjusted EBITDA and net income.Q1 2014 revenue of $132 mln, EBITDA of $29.7 mln, and net income of $4.34 mln - Thomson Reuters I/B/E/S.FY 2014 revenue of $572.56 mln, EBITDA of $150.84 mln and net income of $34.99 mln - Thomson Reuters I/B/E/S.  Full Article

Webmd Health Corp reaffirms Q1, FY 2014 guidance - Conference Call
Sunday, 23 Feb 2014 04:00pm EST 

Webmd Health Corp:Expects Q1 2014 revenue to be about $130-$133 mln.Expects Q1 2014 adjusted EBITDA to be about $28.5-$30.5 mln.Expects Q1 2014 net income as a percentage of revenue to be about 3 pct to 4 pct.Expects FY 2014 revenue to be about $545-$575 mln.Expects FY 2014 adjusted EBITDA to be about $140-$155 mln.Expects FY 2014 net income to be about $27-$39 mln.Q1 2014 revenue of $131 mln, EBITDA of $29.7 mln and EPS of $0.11 - Thomson Reuters I/B/E/S.FY 2014 revenue of $574 mln and EBITDA of $154 mln - Thomson Reuters I/B/E/S.  Full Article

Webmd Health Corp gives Q1 2014 earnings outlook; revenue outlook above analysts' estimates; gives FY 2014 outlook in line with analysts' estimates; announces increase in stock repurchase program
Monday, 10 Feb 2014 04:05pm EST 

Webmd Health Corp:Expects Q1 2014 revenue to be about $130-$133 mln.Expects Q1 2014 adjusted EBITDA to be about $28.5-$30.5 mln.Expects Q1 2014 net income as a percentage of revenue to be about 3 pct to 4 pct.Expects FY 2014 revenue to be about $545-$575 mln.Expects FY 2014 adjusted EBITDA to be about $140-$155 mln.Expects FY 2014 net income to be about $27-$39 mln.Q1 2014 revenue of $123 mln - Thomson Reuters I/B/E/S.FY 2014 revenue of $564 mln, EBITDA of $151 mln, net income of $27 mln - Thomson Reuters I/B/E/S.Says an increase of $50 mln in the amount available under its existing stock repurchase program.Says this increases the amount currently available for repurchases to about $70 mln.Says under the program, it may repurchase shares from time to time in the open market, through block trades or in private transactions, depending on market conditions and other factors.  Full Article

Webmd Health Corp completes private placement of $300 million aggregate principal amount of Notes-Form 8-K
Tuesday, 26 Nov 2013 10:14am EST 

Webmd Health Corp:Says on Nov. 26, the Registrant completed the private placement of $300 million aggregate principal amount of the Notes and entered into an Indenture, with respect to the Notes, with The Bank of New York Mellon Trust Company, N.A.Says net proceeds to the Registrant from the sale of the Notes are estimated to be approximately $291.5 million, after the initial purchaser’s discount and estimated expenses.Says the Registrant intends to use the net proceeds for general corporate purposes, which may include acquisitions, repurchases of its common stock, and working capital.Says the Notes will mature on Dec. 1, 2020, unless previously repurchased or converted in accordance with their terms prior to such date.Says Interest on the Notes is payable semiannually on June 1 and December 1 of each year, commencing on June 1, 2014.Says under the terms of the Notes, holders may surrender their Notes for conversion into Common Stock at an initial conversion rate of 18.9362 shares of Common Stock per $1,000 principal amount of Note.Says this is equivalent to an initial conversion price of approximately $52.81 per share of Common Stock.Says the initial conversion price represents a premium of approximately 36% over the closing price of the Common Stock on the Nasdaq Global Select Market on Nov. 20.Says In the aggregate, the Notes are initially convertible into 5,680,860 shares of Common Stock.  Full Article

Webmd Health Corp Announces Pricing of $300 Million of 1.50% Convertible Notes Due 2020
Thursday, 21 Nov 2013 07:30am EST 

Webmd Health Corp announced the pricing of its private placement of $300 million aggregate principal amount of 1.50% Convertible Notes due 2020. WebMD has also granted the initial purchaser in the offering a 30-day option to purchase up to an additional $50 million aggregate principal amount of notes. WebMD intends to use the net proceeds from the sale of the notes for general corporate purposes, which may include acquisitions, repurchases of WebMD common stock, and working capital.  Full Article

Webmd Health Corp Announces Proposed Offering of Convertible Notes
Wednesday, 20 Nov 2013 04:09pm EST 

Webmd Health Corp announced that it intends to offer $300 million of Convertible Notes due 2020 in a private placement. WebMD also expects to grant the initial purchaser in the proposed offering an option to purchase up to an additional $50 million aggregate principal amount of notes. The notes are being offered only to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933. The notes will be convertible into shares of WebMD's common stock, based on a conversion rate to be determined. Interest on the notes will be payable semiannually in arrears on June 1 and December 1 of each year, beginning on June 1, 2014. The notes will mature on December 1, 2020 unless previously repurchased or converted in accordance with their terms prior to such date. The interest rate, conversion rate, conversion price and other terms of the notes will be determined at the time of pricing of the offering. WebMD intends to use the net proceeds from the sale of the notes for general corporate purposes, which may include acquisitions and repurchases of WebMD common stock, and for working capital.  Full Article

Webmd Health Corp Acquires Avado, Inc.
Tuesday, 29 Oct 2013 04:00pm EDT 

WebMD Health Corp. announced that it has acquired Avado, Inc., a developer of cloud-based patient relationship management (PRM) tools and technologies that enable better communication between consumers and health care professionals.  Full Article

Webmd Health Corp Issues Q4 2013 Revenue, Net Income Guidance In Line with Analysts' Estimates; Q4 2013 EBITDA Guidance Above Analysts' Estimates; Raises FY 2013 Guidance
Tuesday, 29 Oct 2013 04:00pm EDT 

Webmd Health Corp increased its revenue and earnings guidance for fiscal 2013 based on year-to-date actual results and its expectations for continued momentum in its public portals advertising business in the fourth quarter of 2013. For the fourth quarter of 2013, it expects revenue to be in excess of $141 million, Adjusted EBITDA to be in excess of $36 million, and Net income to be in excess of $7.7 million. For fiscal 2013 it expects Revenue to be in excess of $510 million, Adjusted EBITDA to be in excess of $118 million, and Net income to be in excess of $12 million. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $142 million, EBITDA of $34 million and Net income of $8.36 million for fourth quarter of 2013. revenue of $511 million, EBITDA of $114 million and Net income of $12.77 million for fiscal 2013.  Full Article

Search Stocks